glp 1 drugs fda approved for weight loss What's New in Obesity Treatment? Patient education tips for GLP-1,

doi: 10.1177/17562864241281903, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 101

Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration

Clinical trials have demonstrated that GLP-1 agonists can reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death [5, 7]

Ninety-eight patients with obesity and MASH underwent liver magnetic resonance imaging and had blood biomarkers of liver injury and fibrosis measured

Mice in the Geniposide group were intraperitoneally injected with geniposide (200 mg/kg/day), while mice in the Control group and Model group were intraperitoneally injected with an identical volume of saline for 11 weeks